Elite in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

Lorenz Thurner

Kirrberger Str. 100, 
Homburg, SL, DE 
Elite in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Kirrberger Str. 100, 
Homburg, SL, DE 
OverviewLocationsClinical Research

Overview

Lorenz Thurner practices in Homburg, Germany. Mr. Thurner is rated as an Elite expert by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), and Bone Marrow Transplant.

His clinical research consists of co-authoring 96 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).

Gender
Male

Locations

Kirrberger Str. 100, Homburg, SL 66421, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Graft vs Host Disease Prophylaxis in Unrelated Donor Transplantation: a Randomized Clinical Trial Comparing PTCY vs ATG (GRAPPA)
Graft vs Host Disease Prophylaxis in Unrelated Donor Transplantation: a Randomized Clinical Trial Comparing PTCY vs ATG (GRAPPA)
Enrollment Status: Active_not_recruiting
Publish Date: December 20, 2024
Intervention Type: Drug, Biological
Study Drugs: Cyclophosphamide, ATG
Study Phase: Phase 3

96 Total Publications

IL-1 Receptor Antagonist Antibodies in Idiopathic Recurrent Pericarditis.
IL-1 Receptor Antagonist Antibodies in Idiopathic Recurrent Pericarditis.
Journal: JAMA network open
Published: October 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Thurner's expertise for a condition
ConditionClose
View All 36 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile